MYCN and neuroblastoma: Non-histone proteins are also substrates for PRMT5, with glycine-arginine rich (GAR) motifs being the preferred but not exclusive methylation sites and methylation by PRMT5 can alter the stability and activity of key transcription factors including p53 [9], E2F-1 [10,11], and MYCN in neuroblastoma [5].